Related Experiment Video
Updated: Jun 6, 2026

Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
HIV tri-specific killer engagers directly enhance NK cell function and safely expand NK cells in vivo
Ross T Cromarty1, Julien A Clain2, Yvette Soigner1
1Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA.
An HIV cure remains elusive, and many individuals develop comorbidities; therefore, new synergistic strategies to combat HIV are needed. Enhanced natural killer (NK) cell function associates with HIV elite control, primarily through antibody-dependent cellular cytotoxicity (ADCC). We generated tri-specific killer engagers (TriKEs) to enhance NK cell responses against HIV-infected cells. HIV TriKEs, one using the VRC01/07 antibody domains (VRC TriKE) and one using the CD4 ectodomain 1 (CD4 TriKE), promote NK cell function and killing of HIV target cells. NK cells expressing both CD38 and CD57 are major mediators of this function. We performed a dose-escalation study in SIV-uninfected rhesus macaques to assess the safety and pharmacodynamics of our CD4 TriKE. The TriKE is safe and effective at expanding peripheral and lymphoid NK cells in vivo. These findings support TriKEs as a promising safe immunotherapy to recognize and kill HIV-infected cells, with potential for combination cure strategies.
An HIV cure remains elusive, and many individuals develop comorbidities; therefore, new synergistic strategies to combat HIV are needed. Enhanced natural killer (NK) cell function associates with HIV elite control, primarily through antibody-dependent cellular cytotoxicity (ADCC). We generated tri-specific killer engagers (TriKEs) to enhance NK cell responses against HIV-infected cells. HIV TriKEs, one using the VRC01/07 antibody domains (VRC TriKE) and one using the CD4 ectodomain 1 (CD4 TriKE), promote NK cell function and killing of HIV target cells. NK cells expressing both CD38 and CD57 are major mediators of this function. We performed a dose-escalation study in SIV-uninfected rhesus macaques to assess the safety and pharmacodynamics of our CD4 TriKE. The TriKE is safe and effective at expanding peripheral and lymphoid NK cells in vivo. These findings support TriKEs as a promising safe immunotherapy to recognize and kill HIV-infected cells, with potential for combination cure strategies.
Related Concept Videos
Cells of the Innate Immune Response
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...

